Selective Serotonin Reuptake Inhibitor Treatment and Risk of Fractures: a Meta-Analysis of Cohort and Case-Control Studies

Authors

Qing Wu, University of Nevada, Las VegasFollow
A. F. Bencaz, Louisiana State University Health Sciences CenterFollow
J. G. Hentz, Mayo Clinic, ScottsdaleFollow
M. D. Crowell, Mayo Clinic, ScottsdaleFollow

Document Type

Article

Publication Date

2012

Publication Title

Osteoporosis International

Volume

23

Issue

1

First page number:

365

Last page number:

375

Disciplines

Epidemiology | Medicine and Health Sciences

Language

English

Repository Citation

Wu, Q., Bencaz, A. F., Hentz, J. G., Crowell, M. D. (2012). Selective Serotonin Reuptake Inhibitor Treatment and Risk of Fractures: a Meta-Analysis of Cohort and Case-Control Studies. Osteoporosis International, 23(1), 365-375.